Chagas Disease Drug Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC687

Introduction

Chagas disease is tropical parasitic disease caused by trypanosoma cruzi. Chagas disease is transferred by triatomine bugs or kissing bugs. Chagas disease can also spread through mother to fetus during pregnancy, blood transfusions, and sometimes from organ transplantation. The symptoms of this disease in early stage are headache, fever, swollen lymph nodes, and others. The chronic symptom appears after 8-12 weeks including enlargement of ventricles indicating to the heart failure causing death. Hence, growing awareness for this disease may boost chagas disease drug market growth in near future. 

Market Dynamics

Increasing population suffering from chagas disease and increase in research and development (R&D) of innovative products are some of the key drivers for this market growth. Conversely, lack of awareness for treatment, limited approved products in present market, and supply chain problems associated to chagas disease drugs will restraint growth of this market in near future. Rising incidences of chagas disease owing to unhygienic surroundings is expected to boost the growth of this market.

Market Classification

The market can be bifurcated on the basis of drug type, treatment type, distribution channel, and geography. By drug type, chagas disease drug market can be segmented into benznidazole, nifurtimox and others. By treatment type, chagas disease drug market can be segmented into antiparasitic treatment and symptomatic treatment. By distribution channel, chagas disease drug market can be segmented into hospital pharmacies, online pharmacies and retail pharmacies. On the basis of geography, the chagas disease drug market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market

Chagas Disease Drug Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Drug Type, Treatment Type, Distribution Channel, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major players involved in chagas disease drug market include AstraZeneca Plc, Bayer AG, Daiichi Sankyo Co Ltd, Eisai Co Ltd, GlaxoSmithKline Plc, Grupo Praxis Pharmaceutical SA, Humanigen Inc, Kancera AB, Merck & Co Inc, Novartis AG, Oblita Therapeutics BVBA, and Sanofi SA among others.

Market Segmentation

Market By Drug Type

  • Benznidazole
  • Nifurtimox
  • Others

Market By Treatment Type

  • Antiparasitic Treatment
  • Symptomatic Treatment

Market By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Behavioral Health Market (By Disorder: Alcohol Use Disorders, Schizophrenia, Bipolar Disorder, Depression, Anxiety, Post-traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, Others; By Service: Emergency Mental Health Services, Outpatient Counselling, Home-based Treatment Services, Inpatient Hospital Treatment Services, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Behavioral Health market is forecasted to grow at striking CAGR around 2.5 % over the forecast time frame and reach around US$ 240 billion by 2026. Behavioural health involves non-pharmacological therapies for circumstances like mental health, drug abuse disorder, etc. Due to mental illnesses,

Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026. Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimu

Sacral Nerve Stimulation Market (By Product: Implantable, External; By Application: Urinary & Fecal Incontinence, Urge Incontinence, Chronic Anal Fissure, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global sacral nerve stimulation market size is expected to reach over 2.3 USD billion by 2026 at the CAGR 12.1% during the forecast period, 2019-2026. A Sacral nerve stimulation is implanted as a device to control bladder functions by delivering controlled electrical impulses to the sacral nerves that modulate the neural pathways. It is an effective and safe treatment for patients suffering fro

Medical Imaging Workstations Market (By Modality: Computed Tomography, MRI, X-ray; By Component: Visualization Software, Display Units; By Usage Mode: Thin, Thick; By Application: Diagnostic Imaging, Clinical Review; By End User: Hospital and Clinics, Diagnostics Centers, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global market for Medical Imaging Workstations is estimated to grow at a significant rate of 8.5% during the forecasted period and is expected to reach over 2.3 billion by 2026. Medical imaging workstations are used in the hospitals while setting up the equipments. During last few years there is an significant increase in the prevalence of the various diseases and accidents which has increased

Laser Hair Removal Market (End User: Dermatology Clinics, Beauty Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global laser hair removal market value is accounted over USD 3.9 Billion by 2026 and is expected to grow at CAGR 15.4% during the forecast period 2019-2026. The global laser hair removal product market is driven by increased awareness regarding personal appearance and rising health awareness among the population. Additionally, improved standard of living and rising disposable income tremendously affects the laser hair remo

Idiopathic Pulmonary Fibrosis Treatment Market (By Drug Class: Tyrosine Inhibitors, MAPK Inhibitors, Autotaxin Inhibitors; By End User: Hospitals, Long-term Care Facilities, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach over 4.2 USD billion by 2026 and growing at CAGR 11.6% during the forecast period 2019-2026. During last few years, there is a significant increase in the number of respiratory related diseases. Increasing prevalence of the various respiratory diseases, rising geriatric population across the globe, and increasing awareness about health have driven t

Cart Summary